Join Growin Stock Community!

Ardent health partners, llcARDT.US Overview

US StockHealthcare
(No presentation for ARDT)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ARDT AI Insights

ARDT Overall Performance

ARDT AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ARDT Recent Performance

-

Ardent health partners, llc

0.05%

Avg of Sector

-0.31%

S&P500

ARDT PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ARDT Key Information

ARDT Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

ARDT Profile

Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.

Price of ARDT

ARDT FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ARDT Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.43
PE Ratio (TTM)
6.34
Forward PE
4.78
PS Ratio (TTM)
0.21
PB Ratio
1.09
Price-to-FCF
8.54
METRIC
VALUE
vs. INDUSTRY
Gross Margin
18.42%
Net Margin
3.24%
Revenue Growth (YoY)
10.86%
Profit Growth (YoY)
-35.53%
3-Year Revenue Growth
13.00%
3-Year Profit Growth
-38.49%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.43
PE Ratio (TTM)
6.34
Forward PE
4.78
PS Ratio (TTM)
0.21
PB Ratio
1.09
Price-to-FCF
8.54
Gross Margin
18.42%
Net Margin
3.24%
Revenue Growth (YoY)
10.86%
Profit Growth (YoY)
-35.53%
3-Year Revenue Growth
13.00%
3-Year Profit Growth
-38.49%
  • When is ARDT's latest earnings report released?

    The most recent financial report for Ardent health partners, llc (ARDT) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ARDT's short-term business performance and financial health. For the latest updates on ARDT's earnings releases, visit this page regularly.

  • What is the operating profit of ARDT?

    According to the latest financial report, Ardent health partners, llc (ARDT) reported an Operating Profit of 16.46M with an Operating Margin of 1.04% this period, representing a decline of 76.62% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ARDT's revenue growth?

    In the latest financial report, Ardent health partners, llc (ARDT) announced revenue of 1.58B, with a Year-Over-Year growth rate of 8.75%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ARDT have?

    As of the end of the reporting period, Ardent health partners, llc (ARDT) had total debt of 2.28B, with a debt ratio of 0.44. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ARDT have?

    At the end of the period, Ardent health partners, llc (ARDT) held Total Cash and Cash Equivalents of 609.44M, accounting for 0.12 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ARDT go with three margins increasing?

    In the latest report, Ardent health partners, llc (ARDT) did not achieve the “three margins increasing” benchmark, with a gross margin of 16.1%%, operating margin of 1.04%%, and net margin of -1.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ARDT's profit trajectory and future growth potential.

  • Is ARDT's EPS continuing to grow?

    According to the past four quarterly reports, Ardent health partners, llc (ARDT)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.17. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ARDT?

    Ardent health partners, llc (ARDT)'s Free Cash Flow (FCF) for the period is 95.57M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 106.68% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ARDT?

    The latest valuation data shows Ardent health partners, llc (ARDT) has a Price-To-Earnings (PE) ratio of 6.29 and a Price/Earnings-To-Growth (PEG) ratio of 0.15. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.